Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.
Menu

Recursion Pharmaceuticals Inc Cl A (RXRX)

Recursion Pharmaceuticals Inc Cl A (RXRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Businessman touching the brain working of Artificial Intelligence (AI) Automation by Suttiphong Chandaeng via Shutterstock
1 of the Most Interesting AI Stocks in the Market Isn’t a Tech Company Barchart - Tue Jun 23, 3:30PM CDT

Recursion Pharmaceuticals is trying to prove that AI’s next big winner can also come from biotech, and not just from the tech sector.

RXRX : 3.65 (-2.93%)
RHHBY : 52.0200 (+0.50%)
SNY : 43.36 (-1.23%)
Recursion to Participate in Upcoming Investor Conferences GlobeNewswire - Tue Jun 2, 7:00AM CDT

Salt Lake City, UT, June 02, 2026 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX), a leading clinical-stage TechBio company decoding biology to radically improve lives, today announced its participation...

RXRX : 3.65 (-2.93%)
Recursion Reports Grant of Inducement Awards as Permitted by the Nasdaq Listing Rules GlobeNewswire - Fri May 29, 3:30PM CDT

Salt Lake City, UT, May 29, 2026 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, announced that on May 26, 2026, the...

RXRX : 3.65 (-2.93%)
MarketBeat.com
A Deep Dive Into NVIDIA’s Latest Portfolio Moves MarketBeat - Tue May 19, 1:05PM CDT

NVIDIA's latest 13F filing does not tell the story it seems to at first glance. The apparent divergence in its CoreWeave and Nebius holdings is a prime example.

NVDA : 203.96 (+0.58%)
CRWV : 89.89 (+0.21%)
GENB : 15.19 (-3.37%)
INTC : 109.14 (-3.02%)
SNPS : 443.68 (+0.07%)
COHR : 329.25 (+0.61%)
NBIS : 212.20 (-1.85%)
RXRX : 3.65 (-2.93%)
NOK : 12.55 (-2.71%)
LITE : 803.80 (+2.29%)
MRVL : 238.40 (-1.98%)
Recursion Pharmaceuticals: Q1 Earnings Snapshot AP - Wed May 6, 5:36AM CDT

Recursion Pharmaceuticals: Q1 Earnings Snapshot

RXRX : 3.65 (-2.93%)
Recursion Reports First Quarter Financial Results and Provides Business Update GlobeNewswire - Wed May 6, 5:30AM CDT

Multiple milestones achieved or on track across wholly owned and partnered programs  REC-1245 (RBM39 degrader): Early clinical data in solid tumors demonstrate a well-tolerated safety profile and predictable,...

RXRX : 3.65 (-2.93%)
Recursion's AI Drug Platform Approaches Its First Real Clinical Readout—Or Does It Barchart - Tue May 5, 4:32PM CDT

Barchart Research What to Expect from RXRX Earnings RXRX Generated May 5, 2026 Current Price $3.37 EPS Estimate $$-0.30 Consensus Rating Moderate Buy Average Move 4.87% Recursion's AI Drug Platform Approaches...

RXRX : 3.65 (-2.93%)
Recursion Announces Board Transition GlobeNewswire - Thu Apr 30, 3:30PM CDT

Salt Lake City, UT, April 30, 2026 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical-stage TechBio company decoding biology to radically improve lives, today announced that Chris Gibson,...

RXRX : 3.65 (-2.93%)
Recursion to Report First Quarter 2026 Business Updates and Financial Results on May 6 GlobeNewswire - Wed Apr 29, 6:59AM CDT

Salt Lake City, UT, April 29, 2026 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, announced today it will provide...

RXRX : 3.65 (-2.93%)
Recursion to Participate in Upcoming Investor Conferences GlobeNewswire - Tue Apr 7, 7:00AM CDT

Salt Lake City, April 07, 2026 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX), a leading clinical-stage TechBio company decoding biology to radically improve lives, today announced its participation in...

RXRX : 3.65 (-2.93%)

Barchart Exclusives

EQT Stock Is Near a Trough, Attracting Value Investors Ahead of Earnings Barchart - 29 minutes ago
Natural gas producer EQT Corp has had a rough 3 months, as analysts project significantly lower Q2 revenue. But EQT stock is at a 6-month low, attracting value investors, including those shorting 1-month puts. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.